Why the study?
Does intravenous ondansetron reduce hypotensive bradycardic events in patients undergoing shoulder arthroscopy in the sitting position under interscalene block?
Does intravenous ondansetron reduce hypotensive bradycardic events in patients undergoing shoulder arthroscopy in the sitting position under interscalene block?
Prophylactic intravenous ondansetron significantly reduces the incidence of hypotensive bradycardic events during shoulder arthroscopy performed in the sitting position under interscalene block.
Supports prophylactic IV ondansetron in sitting shoulder arthroscopy under interscalene block; extends 5-HT3 antagonist role in regional anesthesia.
PurposeThis study was conducted to test whether blocking the serotonin receptors by intravenous [IV] ondansetron; can help in reducing the hypotensive bradycardic events [HB events] associated with shoulder arthroscopy done in the sitting position under interscalene plexus block [ISB].MethodsOne hundred and fifty patients, scheduled for shoulder arthroscopy in the sitting position under ISB, were randomly assigned to one of three groups receiving either: 4 mg ondansetron, or 8 mg ondansetron or saline.ResultsIV injection of ondansetron 4 mg or 8 mg significantly reduced the incidence of HB events from 20.4% in the saline group to 6.1% after injection of 4 mg ondansetron and 6% after injection of 8 mg ondansetron; p value [0.030].ConclusionIV ondansetron either 4 mg or 8 mg reduces the HB events during shoulder arthroscopy in the sitting position under ISB.
No takes yet. Share an insight, caveat, or question.
Hasanein et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: